{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T03:30:46Z","timestamp":1791862246086,"version":"4.3.4"},"reference-count":50,"publisher":"SAGE Publications","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAD"],"published-print":{"date-parts":[[2021,9,14]]},"abstract":"<jats:p>Background: The global race-dependent association of Alzheimer\u2019s disease (AD) and apolipoprotein E (APOE) genotype is not well understood. Transethnic analysis of APOE could clarify the role of genetics in AD risk across populations. Objective: This study aims to determine how race and APOE genotype affect the risks for AD. Methods: We performed a systematic search of PubMed, Embase, Web of Science, and the Cochrane Library since 1993 to Aug 25, 2020. A total of 10,395 reports were identified, and 133 were eligible for analysis with data on 77,402 participants. Studies contained AD clinical diagnostic and APOE genotype data. Homogeneous data sets were pooled in case-control analyses. Odds ratios and 95% confidence intervals for developing AD were calculated for populations of different races and APOE genotypes. Results: The proportion of APOE genotypes and alleles differed between populations of different races. Results showed that APOE \u025b4 was a risk factor for AD, whereas APOE \u025b2 protected against it. The effects of APOE \u025b4 and \u025b2 on AD risk were distinct in various races, and they were substantially attenuated among Black people. Sub-group analysis found a higher frequency of APOE \u025b4\/\u025b4 and lower frequency of APOE \u025b3\/\u025b3 among early-onset AD than late-onset AD in a combined group and different races. Conclusion: Our meta-analysis suggests that the association of APOE genotypes and AD differ among races. These results enhance our understanding of APOE-related risk for AD across race backgrounds and provide new insights into precision medicine for AD.<\/jats:p>","DOI":"10.3233\/jad-210549","type":"journal-article","created":{"date-parts":[[2021,7,27]],"date-time":"2021-07-27T13:17:10Z","timestamp":1627391830000},"page":"897-906","source":"Crossref","is-referenced-by-count":34,"title":["Race-Related Association between APOE Genotype and Alzheimer\u2019s Disease: A Systematic Review and Meta-Analysis"],"prefix":"10.1177","volume":"83","author":[{"given":"Wei","family":"Qin","sequence":"first","affiliation":[{"name":"Innovation Center for Neurological Disorders and Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenwen","family":"Li","sequence":"additional","affiliation":[{"name":"Innovation Center for Neurological Disorders and Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Wang","sequence":"additional","affiliation":[{"name":"Innovation Center for Neurological Disorders and Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Gong","sequence":"additional","affiliation":[{"name":"Innovation Center for Neurological Disorders and Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Li","sequence":"additional","affiliation":[{"name":"Innovation Center for Neurological Disorders and Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuqing","family":"Shi","sequence":"additional","affiliation":[{"name":"Innovation Center for Neurological Disorders and Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Song","sequence":"additional","affiliation":[{"name":"Innovation Center for Neurological Disorders and Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Li","sequence":"additional","affiliation":[{"name":"Innovation Center for Neurological Disorders and Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangyu","family":"Li","sequence":"additional","affiliation":[{"name":"Innovation Center for Neurological Disorders and Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianping","family":"Jia","sequence":"additional","affiliation":[{"name":"Innovation Center for Neurological Disorders and Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, China"},{"name":"Beijing Key Laboratory of Geriatric Cognitive Disorders, Beijing, China"},{"name":"Clinical Center for Neurodegenerative Disease and Memory Impairment, Capital Medical University, Beijing, China"},{"name":"Center of Alzheimer\u2019s Disease, Beijing Institute for Brain Disorders, Beijing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","reference":[{"key":"10.3233\/JAD-210549_ref1","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S1474-4422(16)00062-4","article-title":"Defeating Alzheimer\u2019s disease and other dementias: A priority for European science and society","volume":"15","author":"Winblad","year":"2016","journal-title":"Lancet Neurol"},{"key":"10.3233\/JAD-210549_ref2","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/S1474-4422(16)00067-3","article-title":"Sex differences in Alzheimer\u2019s disease and other dementias","volume":"15","author":"Mazure","year":"2016","journal-title":"Lancet Neurol"},{"key":"10.3233\/JAD-210549_ref3","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/nrneurol.2012.263","article-title":"Apolipoprotein E and Alzheimer disease: Risk, mechanisms and therapy","volume":"9","author":"Liu","year":"2013","journal-title":"Nat Rev Neurol"},{"key":"10.3233\/JAD-210549_ref4","doi-asserted-by":"crossref","first-page":"2878","DOI":"10.1016\/j.neubiorev.2013.10.010","article-title":"The forgotten APOE allele: A review of the evidence and suggested mechanisms for the protective effect of APOE varepsilon2","volume":"37","author":"Suri","year":"2013","journal-title":"Neurosci Biobehav Rev"},{"key":"10.3233\/JAD-210549_ref5","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1038\/ng0694-180","article-title":"Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease","volume":"7","author":"Corder","year":"1994","journal-title":"Nat Genet"},{"key":"10.3233\/JAD-210549_ref6","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/ng1934","article-title":"Systematic meta-analyses of Alzheimer disease genetic association studies: The AlzGene database","volume":"39","author":"Bertram","year":"2007","journal-title":"Nat Genet"},{"key":"10.3233\/JAD-210549_ref7","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1002\/alz.12153","article-title":"The APOE epsilon4 exerts differential effects on familial and other subtypes of Alzheimer\u2019s disease","volume":"16","author":"Jia","year":"2020","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-210549_ref8","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1001\/jama.1997.03550160069041","article-title":"Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium","volume":"278","author":"Farrer","year":"1997","journal-title":"JAMA"},{"key":"10.3233\/JAD-210549_ref9","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.jalz.2012.12.007","article-title":"Risk factors for mild cognitive impairment among Mexican Americans","volume":"9","author":"O\u2019Bryant","year":"2013","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-210549_ref10","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1001\/jama.279.10.751","article-title":"The APOE-epsilon4 allele and the risk of Alzheimer disease among African Americans, whites, and Hispanics","volume":"279","author":"Tang","year":"1998","journal-title":"JAMA"},{"key":"10.3233\/JAD-210549_ref11","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1001\/archneur.60.2.185","article-title":"Incidence of Alzheimer disease in a biracial urban community: Relation to apolipoprotein E allele status","volume":"60","author":"Evans","year":"2003","journal-title":"Arch Neurol"},{"key":"10.3233\/JAD-210549_ref12","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1001\/archneur.59.4.594","article-title":"Association between apolipoprotein E genotype and Alzheimer disease in African American subjects","volume":"59","author":"Graff-Radford","year":"2002","journal-title":"Arch Neurol"},{"key":"10.3233\/JAD-210549_ref13","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1002\/ana.410370217","article-title":"Apolipoprotein E and Alzheimer\u2019s disease: Ethnic variation in genotypic risks","volume":"37","author":"Maestre","year":"1995","journal-title":"Ann Neurol"},{"key":"10.3233\/JAD-210549_ref14","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.biopsych.2013.06.003","article-title":"Genetics of Alzheimer\u2019s disease in Caribbean Hispanic and African American populations","volume":"75","author":"Reitz","year":"2014","journal-title":"Biol Psychiatry"},{"key":"10.3233\/JAD-210549_ref15","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1001\/archneur.63.3.431","article-title":"Association of apolipoprotein E genotype and Alzheimer disease in African Americans","volume":"63","author":"Murrell","year":"2006","journal-title":"Arch Neurol"},{"key":"10.3233\/JAD-210549_ref16","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.jalz.2014.06.015","article-title":"APOE epsilon4: The most prevalent yet understudied risk factor for Alzheimer\u2019s disease","volume":"10","author":"Michaelson","year":"2014","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-210549_ref17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000334607","article-title":"Prevalence of apolipoprotein E4 genotype and homozygotes (APOE e4\/4) among patients diagnosed with Alzheimer\u2019s disease: A systematic review and meta-analysis","volume":"38","author":"Ward","year":"2012","journal-title":"Neuroepidemiology"},{"key":"10.3233\/JAD-210549_ref18","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1002\/gps.4440","article-title":"Association between DCHS2 gene and mild cognitive impairment and Alzheimer\u2019s disease in an elderly Brazilian sample","volume":"31","author":"Vieira","year":"2016","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.3233\/JAD-210549_ref19","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1002\/ana.410270412","article-title":"The prevalence of dementia and Alzheimer\u2019s disease in Shanghai, China: Impact of age, gender, and education","volume":"27","author":"Zhang","year":"1990","journal-title":"Ann Neurol"},{"key":"10.3233\/JAD-210549_ref20","first-page":"255","article-title":"[Anxiety disorders in the fourth edition of the classification of mental disorders prepared by the American Psychiatric Association: Diagnostic and statistical manual of mental disorders (DMS-IV \u2013options book]","volume":"28","author":"Rabe-Jablonska","year":"1994","journal-title":"Psychiatr Pol"},{"key":"10.3233\/JAD-210549_ref21","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1212\/WNL.34.7.939","article-title":"Clinical diagnosis of Alzheimer\u2019s disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer\u2019s Disease","volume":"34","author":"McKhann","year":"1984","journal-title":"Neurology"},{"key":"10.3233\/JAD-210549_ref22","doi-asserted-by":"crossref","first-page":"248","DOI":"10.3389\/fnagi.2017.00248","article-title":"ApoE rs429358 and rs7412 polymorphism and gender differences of serum lipid profile and cognition in aging Chinese population","volume":"9","author":"Zhen","year":"2017","journal-title":"Front Aging Neurosci"},{"key":"10.3233\/JAD-210549_ref23","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1126\/science.8346443","article-title":"Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer\u2019s disease in late onset families","volume":"261","author":"Corder","year":"1993","journal-title":"Science"},{"key":"10.3233\/JAD-210549_ref24","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1038\/s41588-019-0358-2","article-title":"Genetic meta-analysis of diagnosed Alzheimer\u2019s disease identifies new risk loci and implicates Abeta, tau, immunity and lipid processing","volume":"51","author":"Kunkle","year":"2019","journal-title":"Nat Genet"},{"key":"10.3233\/JAD-210549_ref25","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/S1474-4422(20)30412-9","article-title":"APOE and Alzheimer\u2019s disease: Advances in genetics, pathophysiology, and therapeutic approaches","volume":"20","author":"Serrano-Pozo","year":"2021","journal-title":"Lancet Neurol"},{"key":"10.3233\/JAD-210549_ref26","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.neuron.2020.10.008","article-title":"Apolipoprotein E: Structural insights and links to Alzheimer disease pathogenesis","volume":"109","author":"Chen","year":"2021","journal-title":"Neuron"},{"key":"10.3233\/JAD-210549_ref27","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1001\/jama.2020.15085","article-title":"APOE varepsilon4 allele testing and risk of Alzheimer disease","volume":"325","author":"Choudhury","year":"2021","journal-title":"JAMA"},{"key":"10.3233\/JAD-210549_ref28","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1212\/WNL.56.1.49","article-title":"Incidence of AD in African-Americans, Caribbean Hispanics, and Caucasians in northern Manhattan","volume":"56","author":"Tang","year":"2001","journal-title":"Neurology"},{"key":"10.3233\/JAD-210549_ref29","first-page":"574","article-title":"Relative risk of Alzheimer disease and age-at-onset distributions, based on APOE genotypes among elderly African Americans, Caucasians, and Hispanics in New York City","volume":"58","author":"Tang","year":"1996","journal-title":"Am J Hum Genet"},{"key":"10.3233\/JAD-210549_ref30","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/j.neuron.2019.01.056","article-title":"A quarter century of APOE and Alzheimer\u2019s disease: Progress to date and the path forward","volume":"101","author":"Belloy","year":"2019","journal-title":"Neuron"},{"key":"10.3233\/JAD-210549_ref31","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1176\/ajp.152.10.1485","article-title":"Prevalence of Alzheimer\u2019s disease and dementia in two communities: Nigerian Africans and African Americans","volume":"152","author":"Hendrie","year":"1995","journal-title":"Am J Psychiatry"},{"key":"10.3233\/JAD-210549_ref32","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/S0895-4356(98)00024-9","article-title":"The prevalence and 3-year incidence of dementia in older Black and White community residents","volume":"51","author":"Fillenbaum","year":"1998","journal-title":"J Clin Epidemiol"},{"key":"10.3233\/JAD-210549_ref33","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1002\/ana.410420418","article-title":"Apolipoprotein E-associated risk for Alzheimer\u2019s disease in the African-American population is genotype dependent","volume":"42","author":"Sahota","year":"1997","journal-title":"Ann Neurol"},{"key":"10.3233\/JAD-210549_ref34","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1016\/j.jalz.2019.07.016","article-title":"Local ancestry at APOE modifies Alzheimer\u2019s disease risk in Caribbean Hispanics","volume":"15","author":"Blue","year":"2019","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-210549_ref35","doi-asserted-by":"crossref","first-page":"141.e1","DOI":"10.1016\/j.neurobiolaging.2019.11.007","article-title":"APOE region molecular signatures of Alzheimer\u2019s disease across races\/ethnicities","volume":"87","author":"Kulminski","year":"2020","journal-title":"Neurobiol Aging"},{"key":"10.3233\/JAD-210549_ref36","doi-asserted-by":"crossref","first-page":"8068","DOI":"10.1038\/s41598-018-26398-1","article-title":"Brain APOE expression quantitative trait loci-based association study identified one susceptibility locus for Alzheimer\u2019s disease by interacting with APOE epsilon4","volume":"8","author":"Zhang","year":"2018","journal-title":"Sci Rep"},{"key":"10.3233\/JAD-210549_ref37","doi-asserted-by":"crossref","first-page":"3310","DOI":"10.1038\/s41467-019-10945-z","article-title":"Non-coding variability at the APOE locus contributes to the Alzheimer\u2019s risk","volume":"10","author":"Zhou","year":"2019","journal-title":"Nat Commun"},{"key":"10.3233\/JAD-210549_ref38","doi-asserted-by":"crossref","first-page":"e1007791","DOI":"10.1371\/journal.pgen.1007791","article-title":"Ancestral origin of ApoE epsilon4 Alzheimer disease risk in Puerto Rican and African American populations","volume":"14","author":"Rajabli","year":"2018","journal-title":"PLoS Genet"},{"key":"10.3233\/JAD-210549_ref39","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1086\/303070","article-title":"Apolipoprotein E variation at the sequence haplotype level: Implications for the origin and maintenance of a major human polymorphism","volume":"67","author":"Fullerton","year":"2000","journal-title":"Am J Hum Genet"},{"key":"10.3233\/JAD-210549_ref40","doi-asserted-by":"crossref","first-page":"467","DOI":"10.3233\/JAD-200228","article-title":"Characterizing clinical and neuropathological traits of APOE haplotypes in African Americans and Europeans","volume":"78","author":"Mezlini","year":"2020","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-210549_ref41","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s12868-018-0413-4","article-title":"Haplotype analysis of APOE intragenic SNPs","volume":"19","author":"Babenko","year":"2018","journal-title":"BMC Neurosci"},{"key":"10.3233\/JAD-210549_ref42","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1001\/jamaneurol.2018.4519","article-title":"Association of apolipoprotein E with intracerebral hemorrhage risk by race\/ethnicity: A meta-analysis","volume":"76","author":"Marini","year":"2019","journal-title":"JAMA Neurol"},{"key":"10.3233\/JAD-210549_ref43","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/ene.13439","article-title":"Alzheimer\u2019s disease","volume":"25","author":"Lane","year":"2018","journal-title":"Eur J Neurol"},{"key":"10.3233\/JAD-210549_ref44","doi-asserted-by":"crossref","first-page":"297","DOI":"10.3233\/JAD-160424","article-title":"Physical exercise moderates the relationship of apolipoprotein E (APOE) genotype and dementia risk: A population-based study","volume":"56","author":"Fenesi","year":"2017","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-210549_ref45","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/mp.2011.136","article-title":"African ancestry protects against Alzheimer\u2019s disease-related neuropathology","volume":"18","author":"Schlesinger","year":"2013","journal-title":"Mol Psychiatry"},{"key":"10.3233\/JAD-210549_ref46","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1001\/jamaneurol.2015.1424","article-title":"Genetic modifiers of age at onset in carriers of the G206A mutation in PSEN1 with familial Alzheimer disease among Caribbean Hispanics","volume":"72","author":"Lee","year":"2015","journal-title":"JAMA Neurol"},{"key":"10.3233\/JAD-210549_ref47","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s12920-018-0363-9","article-title":"DNA methylation in the APOE genomic region is associated with cognitive function in African Americans","volume":"11","author":"Liu","year":"2018","journal-title":"BMC Med Genomics"},{"key":"10.3233\/JAD-210549_ref48","first-page":"300","article-title":"Differences between early and late onset Alzheimer\u2019s disease","volume":"2","author":"Panegyres","year":"2013","journal-title":"Am J Neurodegener Dis"},{"key":"10.3233\/JAD-210549_ref49","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1212\/WNL.48.1.139","article-title":"ApoE-4 and age at onset of Alzheimer\u2019s disease: The NIMH genetics initiative","volume":"48","author":"Blacker","year":"1997","journal-title":"Neurology"},{"key":"10.3233\/JAD-210549_ref50","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1159\/000322368","article-title":"Apolipoprotein E polymorphism and age at onset of Alzheimer\u2019s disease in a quadriethnic sample","volume":"30","author":"Kwon","year":"2010","journal-title":"Dement Geriatr Cogn Disord"}],"container-title":["Journal of Alzheimer's Disease"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/JAD-210549","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T10:06:50Z","timestamp":1777370810000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/JAD-210549"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,14]]},"references-count":50,"journal-issue":{"issue":"2"},"URL":"https:\/\/doi.org\/10.3233\/jad-210549","relation":{},"ISSN":["1387-2877","1875-8908"],"issn-type":[{"value":"1387-2877","type":"print"},{"value":"1875-8908","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,14]]}}}